The Silicon Review
27 August, 2020
CureApp, Inc. received regulatory authorization for sale and manufacturing of the CureApp SC Nicotine Addiction Treatment App and CO Checker. The new solution is Asia’s first therapeutics app, and it got approval from the Ministry of Health, Labor, and Welfare. The company is looking forward to releasing the app by the end of FY2020, and it is working relentlessly with new plans to receive insurance reimbursement. The CureApp SC was made to aid patients receiving outpatient treatment, which is a new attempt to help them quit smoke from their homes.
There are three notable components in the app: a doctor app, a patient app, and a portable CO checker. The patient app will take advantage of the fact that people always have their smartphones with them, and this is a better way to deliver personalized guidance based on their therapy condition and status. The CO checker will help the patients in measuring the level of carbon monoxide in their breath. Before the app’s advent, there used to be a gap in treating patients in the office and home setting. By helping the patients in a familiar setup success rate of smoking cessation was improved notably.
HDFC Bank is Qfix's main distribution partner Pine Labs has announced that it has acquired Qfix, a Mumbai-based online payments startup. This acquisi...
Salesforce has announced permanent presence in Thailand by launching its new office in the country’s capital, Bangkok. The permanent presence wi...
Garment Mantra Lifestyle, a popular name in the Indian fashion retail segment, recently made an announcement that the company is expanding its retail ...
The ongoing Covid pandemic had significantly increased the number of mobile and internet users worldwide. The high amount of usage is expected to drop...